1. Laskin, J, Liu, S V, Tolba, K, Solca, F, Duruisseaux, M. 2020. NRG1 fusion-driven tumors: biology, detection, and the therapeutic role of afatinib and other ErbB-targeting agents. In Annals of oncology : official journal of the European Society for Medical Oncology, 31, 1693-1703. doi:10.1016/j.annonc.2020.08.2335. https://pubmed.ncbi.nlm.nih.gov/32916265/
2. Grego-Bessa, Joaquim, Gómez-Apiñaniz, Paula, Prados, Belén, MacGrogan, Donal, de la Pompa, José Luis. 2023. Nrg1 Regulates Cardiomyocyte Migration and Cell Cycle in Ventricular Development. In Circulation research, 133, 927-943. doi:10.1161/CIRCRESAHA.123.323321. https://pubmed.ncbi.nlm.nih.gov/37846569/
3. Liu, Stephen V. 2021. NRG1 fusions: Biology to therapy. In Lung cancer (Amsterdam, Netherlands), 158, 25-28. doi:10.1016/j.lungcan.2021.05.011. https://pubmed.ncbi.nlm.nih.gov/34098222/
4. Kim, Dong-Wan, Schram, Alison M, Hollebecque, Antoine, Ford, Jim, Goto, Koichi. 2024. The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions. In Future oncology (London, England), 20, 1057-1067. doi:10.2217/fon-2023-0824. https://pubmed.ncbi.nlm.nih.gov/38348690/
5. Gupta, Brinda, Gosa Barrett, Laura, Liu, Stephen V. 2024. NRG1 Fusions in NSCLC: Being eNRGy Conscious. In Lung Cancer (Auckland, N.Z.), 15, 143-148. doi:10.2147/LCTT.S464626. https://pubmed.ncbi.nlm.nih.gov/39376790/
6. Trombetta, Domenico, Rossi, Antonio, Fabrizio, Federico P, Fazio, Vito M, Muscarella, Lucia A. . NRG1-ErbB Lost in Translation: A New Paradigm for Lung Cancer? In Current medicinal chemistry, 24, 4213-4228. doi:10.2174/0929867324666170911170554. https://pubmed.ncbi.nlm.nih.gov/28901268/
智鼠故事 
